Express Scripts shares languish as Anthem dispute weighs

NEW YORK, June 24 (Reuters) - As a pharmacy benefits manager geared toward holding down prescription costs, Express Scripts would appear to be in a sweet spot with rising political and public pressure on drug prices, but its stock has struggled this year.